FDA approves new medication intended to enhance sexual desire in women
The Washington Post (6/21, Cha, McGinley) reported that on Friday, the FDA “approved sales of a new drug intended to enhance sexual desire in women.” The Post added, “Marketed as Vyleesi, also known as bremelanotide, the medication is a shot that comes in a push pen device that can be self-administered as needed for premenopausal women who experience marked distress as a result of low sexual desire.”
The AP (6/21, Perrone) reported that “the approval was based on women’s responses to questionnaires that showed increases in sexual desire and decreases in stress related to sex,” although “the women didn’t report having more sex, the original goal for the drug.”
